HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hirsch, I. B. Search for Related Content PubMed Articles by Hirsch, I. B. Social Bookmarking                What's this?

Promises, Promises

In the early 1970s, we were told that islet cell transplantation was about to become a reality and that diabetes would be cured. In 1980, I remember being told that islet cell transplantation would be performed routinely and safely in human type 1 diabetes by 1985. Needless to say, those promises led to much disappointment, despite the fact that there is now great reason for optimism in this area.1

There have been other promises unfulfilled through the years. Non-invasive glucose sensors, closed-loop insulin pumps, and safe and effective antiobesity drugs remain unattained goals. Likewise, drugs to specifically treat diabetes-related complications have not been successful. Both the aldose reductase inhibitors and advanced glycosylation end product inhibitors have failed to retard complications as initially hoped.

One key problem well appreciated today is that results of studies employing animal models do not necessarily translate to human diabetes. As the late Julio Santiago, a well-known researcher and teacher, once said, "You can almost look at a rat and prevent islet cell rejection." Would that the same . . . [Full Text of this Article]

REFERENCES

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?